Insurance

Unipol’s 2026 share‑buyback shows how small buy‑back volumes can inflate EPS and reward executives, raising governance questions and impacting policyholders.

Fidelity National Financial’s Q2 earnings fell short of Wall Street, with higher loss ratios from rising cyber‑ and climate claims, yet the company’s tech‑driven underwriting and reserve strategy aims to offset volatility and strengthen future perfo…

Medibank Private’s latest filing shows a cautious stance amid shifting underwriting trends, rising mental‑health claims, and tech‑driven pricing, offering insight into its future strategy.

Legal & General pledges £1 billion to debt‑for‑nature swaps, blending actuarial risk, TCFD compliance, and AI‑powered claims to boost ESG returns and climate impact.

Uncover hidden risks in Allianz SE’s latest earnings: beyond headline profits, examine opaque digital‑health deals, dividend sustainability, and executive pay gaps.

FNFI shares dip after earnings miss, but revenue tops expectations, revealing a company sharpening its title‑insurance pipeline and eyeing strategic M&A for growth.

QBE’s sale of its trade‑credit and surety arm to Swiss Re sharpens its focus on high‑margin commercial underwriting, cuts risk‑heavy exposure, and boosts capital efficiency while leveraging tech‑driven claims analytics for smarter pricing.

Fidelity National Financial’s latest earnings show a modest EPS miss but $1.45 billion revenue beat, while regulatory pressures, fintech competition, and potential M&A shape its future upside.

Fairfax Financial’s Q4 2026 earnings call shows stronger P&C and reinsurance earnings, IFRS 17 compliance, and a profit‑turning India arm, offering defensive growth and attractive risk‑managed returns.

Chubb’s new actuarial leadership and Citi’s upgraded price target signal stronger underwriting discipline, capital efficiency and global risk alignment for sustained profitability.